Violation Tracker Parent Company Summary
|Top 5 Offense Groups (Groups Defined)||Penalty Total||Number of Records|
|Top 5 Primary Offense Types||Penalty Total||Number of Records|
|False Claims Act and related||$489,458,415||15|
|drug or medical equipment safety violation||$55,781,039||2|
|price-fixing or anti-competitive practices||$53,650,000||3|
|Foreign Corrupt Practices Act||$25,200,000||1|
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Aventis; Aventis Pharmaceutical Inc.; Aventis Pharmaceutical L.P.; Aventis Pharmaceuticals Inc.; Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC; GENZYME; Hoechst AG; ROUSSEL UCLAF SA; SANOFI; Sanofi US Services, Inc.; Sanofi-Aventis; Sanofi-Aventis U.S. LLC
For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.
For a summary of this company's federal contracts, see its page on Fedspending.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
Individual Penalty Records:Click on the company or penalty amount for more information on each case.
|Company||Primary Offense Type||Year||Agency||Penalty Amount|
|Aventis Pharmaceuticals Inc.||False Claims Act and related||2007||DOJ_CIVIL||$190,000,000|
|Sanofi-Aventis U.S. Inc.||False Claims Act and related||2012||DOJ_CIVIL||$109,000,000|
|Aventis Pharmaceutical Inc.||False Claims Act and related||2009||DOJ_CIVIL||$95,500,000|
|Aventis Pharmaceutical Inc.||False Claims Act and related||2009||MULTI-AG||(*) $40,000,000|
|Aventis Pharmaceuticals Inc.||price-fixing or anti-competitive practices||2003||MULTI-AG||$40,000,000|
|Genzyme Corporation||drug or medical equipment safety violation||2015||FDA||$32,587,439|
|Sanofi||Foreign Corrupt Practices Act||2018||SEC||$25,200,000|
|Roussel Uclaf S.A.||drug or medical equipment safety violation||2001||USAO||$23,193,600|
|Genzyme Corp.||False Claims Act and related||2013||DOJ_CIVIL||$22,280,000|
|Genzyme Corp.||False Claims Act and related||2013||MULTI-AG||(*) $22,280,000|
|Sanofi-Pasteur||False Claims Act and related||2017||DOJ_CIVIL||$19,868,194|
|Sanofi-Aventis U.S. LLC||employment discrimination||2010||private lawsuit-federal||$15,360,000|
|Aventis Pharmaceutical L.P.||False Claims Act and related||2009||AL-AG||$14,833,333|
|Aventis Pharmaceuticals||False Claims Act and related||2019||IL-AG||$14,708,388|
|Hoechst AG||price-fixing or anti-competitive practices||2003||DOJ_ANTITRUST||$12,000,000|
|Sanofi-Aventis U.S., LLC||False Claims Act and related||2020||USAO||$11,850,000|
|Aventis Pharmaceuticals Inc.||False Claims Act and related||2007||MULTI-AG||(*) $10,645,600|
|Aventis||False Claims Act and related||2013||LA-AG||$7,000,000|
|Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC||False Claims Act and related||2012||KY-AG||$2,290,000|
|Aventis Pharmaceuticals, Inc.||price-fixing or anti-competitive practices||2012||MULTI-AG||$1,650,000|
|Sanofi-Aventis||consumer protection violation||2019||WV-AG||$1,600,000|
|Aventis Pharmaceuticals Inc.||False Claims Act and related||2010||NJ-AG||$1,300,000|
|Sanofi-Aventis U.S. LLC||False Claims Act and related||2012||ID-AG||$828,500|
|Sanofi US Services, Inc.||kickbacks and bribery||2013||MULTI-AG||$617,000|
|SANOFI PASTEUR INC.||workplace safety or health violation||2014||OSHA||$7,000|